Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) has been given an average rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $5.1875.
A number of equities research analysts have recently commented on ASPN shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Roth Capital reissued a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a research note on Friday, May 8th. Barclays increased their target price on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a research note on Monday, May 11th. Finally, Wall Street Zen upgraded shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.
View Our Latest Research Report on ASPN
Hedge Funds Weigh In On Aspen Aerogels
Aspen Aerogels Price Performance
Shares of ASPN stock opened at $4.50 on Friday. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32. Aspen Aerogels has a 12-month low of $2.30 and a 12-month high of $9.78. The firm has a fifty day moving average of $5.59 and a 200-day moving average of $4.35. The firm has a market capitalization of $372.55 million, a price-to-earnings ratio of -3.31 and a beta of 2.98.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $37.88 million for the quarter, compared to analyst estimates of $36.58 million. Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The business’s quarterly revenue was down 51.8% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.06) EPS. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. On average, equities research analysts forecast that Aspen Aerogels will post -0.8 earnings per share for the current year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Recommended Stories
- Five stocks we like better than Aspen Aerogels
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
